XK
VRTX icon

Xact Kapitalforvaltning’s Vertex Pharmaceuticals VRTX Stock Holding History

Xact Kapitalforvaltning’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$13.5M Sell
56,640
-7,343
-11% -$1.68M 0.29% 69
2019
Q4 		$14M Buy
63,983
+204
+0.3% +$41.3K 0.24% 82
2019
Q3 		$10.8M Buy
63,779
+5,327
+9% +$942K 0.21% 94
2019
Q2 		$10.7M Buy
58,452
+2,910
+5% +$509K 0.22% 89
2019
Q1 		$10.2M Buy
55,542
+10,340
+23% +$1.91M 0.23% 81
2018
Q4 		$7.49M Buy
45,202
+648
+1% +$112K 0.19% 96
2018
Q3 		$8.59M Sell
44,554
-3,269
-7% -$582K 0.18% 108
2018
Q2 		$8.13M Buy
47,823
+1,393
+3% +$216K 0.17% 119
2018
Q1 		$7.57M Buy
46,430
+2,235
+5% +$365K 0.17% 119
2017
Q4 		$6.62M Buy
44,195
+5,882
+15% +$871K 0.16% 135
2017
Q3 		$5.83M Buy
38,313
+2,464
+7% +$371K 0.17% 141
2017
Q2 		$4.62M Buy
35,849
+126
+0.4% +$15.2K 0.14% 167
2017
Q1 		$3.91M Buy
35,723
+821
+2% +$72.3K 0.12% 199
2016
Q4 		$2.57M Buy
34,902
+2,752
+9% +$224K 0.09% 253
2016
Q3 		$2.8M Buy
+32,150
New +$3.04M 0.1% 237

Other funds holding VRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Xact Kapitalforvaltning's VRTX Position: Q1 2020 in Review

Xact Kapitalforvaltning reduced its Vertex Pharmaceuticals (VRTX) stake by 11% in Q1 2020, selling an estimated $1.68M and leaving 56,640 shares worth $13.5M. The position accounts for 0.29% of the portfolio, ranked #69.

Xact Kapitalforvaltning first reported a position in VRTX in Q3 2016 and has held it in 15 quarters since. The position peaked at $14M in Q4 2019. 856 funds tracked by Wall St. Rank hold VRTX as of Q1 2020.

  • Xact Kapitalforvaltning held 56,640 shares of Vertex Pharmaceuticals worth $13.5M as of Q1 2020.
  • Xact Kapitalforvaltning sold 7,343 Vertex Pharmaceuticals shares in Q1 2020, an estimated $1.68M.
  • Vertex Pharmaceuticals made up 0.29% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #69 holding.
  • Xact Kapitalforvaltning first reported a position in Vertex Pharmaceuticals in Q3 2016 and has held it in 15 quarters since.
  • Xact Kapitalforvaltning's Vertex Pharmaceuticals position peaked at $14M in Q4 2019.
  • 856 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.